Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marianne Cunnington

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Neurology|March 23, 2005
Lamotrigine and the risk of malformations in pregnancyMarianne Cunnington, Patricia Tennis,
International Review of Neurobiology|October 22, 2008
Pregnancy registries: strengths, weaknesses, and bias interpretation of pregnancy registry dataMarianne Cunnington, John Messenheimer
Headache|October 7, 2009
The safety of sumatriptan and naratriptan in pregnancy: what have we learned?Marianne Cunnington, Sara Ephross, Paige Churchill
Epilepsia|March 27, 2007
Effect of dose on the frequency of major birth defects following fetal exposure to lamotrigine monotherapy in an international observational studyMarianne Cunnington, Sandy Ferber, George Quartey, et al.
Current Opinion in Infectious Diseases|April 25, 2013
Genitourinary pathogens and preterm birthMarianne Cunnington, Christini Kortsalioudaki, Paul Heath
Birth Defects Research. Part A, Clinical and Molecular Teratology|June 25, 2009
Regarding the need, or lack thereof, of a comparator group for pregnancy registriesRachel Charlton, Marianne Cunnington, John Weil, et al.
Birth Defects Research|August 10, 2020
A model for human and animal data integration: Weight of evidence strategyKeele E Wurst, Kelsey M Sumner, Dinesh Stanislaus, et al.
Pharmacoepidemiology and Drug Safety|April 3, 2008
Risk of ischaemic cardiovascular events from selective cyclooxygenase-2 inhibitors in osteoarthritisMarianne Cunnington, David Webb, Nawab Qizilbash, et al.
Pharmacoepidemiology and Drug Safety|July 1, 2014
Advantages and problems with pregnancy registries: observations and surprises throughout the life of the International Lamotrigine Pregnancy RegistrySusan Sinclair, Marianne Cunnington, John Messenheimer, et al.
Vaccine|September 28, 2015
Lessons learnt from enrolment and follow up of pregnant women and their infants in clinical trials in South Africa, a low-middle income countryClare L Cutland, Marianne Cunnington, Morounfolu Olugbosi, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Neurology|March 23, 2005
Lamotrigine and the risk of malformations in pregnancyMarianne Cunnington, Patricia Tennis,
International Review of Neurobiology|October 22, 2008
Pregnancy registries: strengths, weaknesses, and bias interpretation of pregnancy registry dataMarianne Cunnington, John Messenheimer
Headache|October 7, 2009
The safety of sumatriptan and naratriptan in pregnancy: what have we learned?Marianne Cunnington, Sara Ephross, Paige Churchill
Epilepsia|March 27, 2007
Effect of dose on the frequency of major birth defects following fetal exposure to lamotrigine monotherapy in an international observational studyMarianne Cunnington, Sandy Ferber, George Quartey, et al.
Current Opinion in Infectious Diseases|April 25, 2013
Genitourinary pathogens and preterm birthMarianne Cunnington, Christini Kortsalioudaki, Paul Heath
Birth Defects Research. Part A, Clinical and Molecular Teratology|June 25, 2009
Regarding the need, or lack thereof, of a comparator group for pregnancy registriesRachel Charlton, Marianne Cunnington, John Weil, et al.
Birth Defects Research|August 10, 2020
A model for human and animal data integration: Weight of evidence strategyKeele E Wurst, Kelsey M Sumner, Dinesh Stanislaus, et al.
Pharmacoepidemiology and Drug Safety|April 3, 2008
Risk of ischaemic cardiovascular events from selective cyclooxygenase-2 inhibitors in osteoarthritisMarianne Cunnington, David Webb, Nawab Qizilbash, et al.
Pharmacoepidemiology and Drug Safety|July 1, 2014
Advantages and problems with pregnancy registries: observations and surprises throughout the life of the International Lamotrigine Pregnancy RegistrySusan Sinclair, Marianne Cunnington, John Messenheimer, et al.
Vaccine|September 28, 2015
Lessons learnt from enrolment and follow up of pregnant women and their infants in clinical trials in South Africa, a low-middle income countryClare L Cutland, Marianne Cunnington, Morounfolu Olugbosi, et al.
Pageof 3